Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013596-15-000003
Filing Date
2015-06-01
Accepted
2015-06-01 20:26:44
Documents
1
Period of Report
2015-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3038
  Complete submission text file 0001013596-15-000003.txt   4632
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8742 Services-Management Consulting Services

Mailing Address 579 RUE LAJEUNESSE LAVAL A8 H7X 3K4
Business Address
Slilaty Steve N. (Reporting) CIK: 0001474684 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52898 | Film No.: 15905072